ThesisSingle nucleotide polymorphism analysis of Oligo adenylate synthatase and Interleukin 1 B genes in chronic HCV associated end stage liver disease
ThesisSingle nucleotide polymorphism analysis of Oligo adenylate synthatase and Interleukin 1 B genes in chronic HCV associated end stage liver disease
ThesisThe clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin
ThesisThe clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin
ThesisSingle nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children
ThesisSingle nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children
ThesisStudy of prediction of response to pegylated interferon plus ribavirin in hepatitis C patients by IL28B gene variation and its relation to other different predictors
ThesisStudy of prediction of response to pegylated interferon plus ribavirin in hepatitis C patients by IL28B gene variation and its relation to other different predictors
ThesisImpact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy
ThesisImpact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy
ThesisOsteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C
ThesisOsteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C
ThesisStudying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment
ThesisStudying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment
ThesisStudying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment
ThesisStudying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment
ArticleInterleukin 28b Single Nucleotide Polymorphism (rs8099917) as a Predictive Factor of Response to Pegylated-IFN/Ribavirintherapy in Chronic HCV Patients
ArticleInterleukin 28b Single Nucleotide Polymorphism (rs8099917) as a Predictive Factor of Response to Pegylated-IFN/Ribavirintherapy in Chronic HCV Patients